VSee Health, Inc. (VSEE) Financial Ratios
5 years of historical data (2020–2024) · Healthcare · Medical - Healthcare Information Services
EV/EBITDA
N/A
—
5yr avg: N/A
P/FCF
N/A
—
5yr avg: N/A
P/B Ratio
N/A
—
5yr avg: N/A
ROE
↓
N/A
—
5yr avg: 13.8%
30Y Low-1%·High42%
Debt/EBITDA
N/A
—
5yr avg: N/A
Percentile shows where the current value sits in 30-year historical distribution. Sparklines show 5-year trend.
VSEE Valuation Multiples
Price-based multiples — how expensive the stock is relative to earnings, sales, book value, and cash flow
VSee Health, Inc. currently has a negative P/E ratio, indicating the company is operating at a loss on a trailing-twelve-month basis.
| Metric | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Market Cap | $3M | $14M | — | — | — | — |
| Enterprise Value | $12M | $23M | — | — | — | — |
| P/E Ratio → | -0.03 | — | — | — | — | — |
| P/S Ratio | 0.28 | 1.33 | — | — | — | — |
| P/B Ratio | — | — | — | — | — | — |
| P/FCF | — | — | — | — | — | — |
| P/OCF | — | — | — | — | — | — |
P/E links to full P/E history page with 30-year chart
VSEE EV Ratios
Enterprise-value multiples — capital-structure-neutral measures of total business value
| Metric | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| EV / Revenue | — | 2.22 | — | — | — | — |
| EV / EBITDA | — | — | — | — | — | — |
| EV / EBIT | — | — | — | — | — | — |
| EV / FCF | — | — | — | — | — | — |
VSEE Profitability
Margins and return-on-capital ratios measuring operating efficiency
VSee Health, Inc. earns an operating margin of -596.4%. Operating margins have compressed from -26.3% to -596.4% over the past 3 years, signaling potential cost pressures or competitive headwinds.
Margins
Full margin charts and quarterly trend are on the Earnings History page
| Metric | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Gross Margin | 68.9% | 68.9% | 66.5% | 75.8% | 80.7% | 80.3% |
| Operating Margin | -596.4% | -596.4% | -32.5% | -26.3% | 3.4% | 5.9% |
| Net Profit Margin | -553.7% | -553.7% | -65.3% | -13.1% | 6.5% | 3.8% |
Return on Capital
| Metric | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| ROE | — | — | — | -1.5% | 0.8% | 42.1% |
| ROA | -554.9% | -554.9% | -220.2% | -1.4% | 0.8% | 9.5% |
| ROIC | -1749.8% | -1749.8% | — | -2.2% | 0.3% | — |
| ROCE | -6327.9% | -6327.9% | — | -2.9% | 0.4% | 65.8% |
VSEE Leverage & Debt
Solvency and debt-coverage ratios — lower is generally safer
Net debt stands at $9M ($10M total debt minus $326115 cash).
| Metric | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Debt / Equity | — | — | — | — | — | 0.22 |
| Debt / EBITDA | — | — | — | — | — | — |
| Net Debt / Equity | — | — | — | — | -0.01 | -1.05 |
| Net Debt / EBITDA | — | — | — | — | — | — |
| Debt / FCF | — | — | — | — | — | -0.81 |
| Interest Coverage | -293.91 | -293.91 | -0.86 | -13.34 | — | — |
VSEE Liquidity & Efficiency
Short-term solvency ratios and asset-utilisation metrics
The current ratio of 0.16x is below 1.0, meaning current liabilities exceed current assets. The current ratio has declined from 0.29x to 0.16x over the past 3 years.
| Metric | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Current Ratio | 0.16 | 0.16 | 0.16 | 0.29 | 6.62 | 0.70 |
| Quick Ratio | 0.16 | 0.16 | 0.16 | 0.29 | 6.62 | 0.70 |
| Cash Ratio | 0.02 | 0.02 | 0.02 | 0.09 | 4.13 | 0.37 |
| Asset Turnover | — | 0.52 | 7.16 | 2.44 | 0.06 | 2.50 |
| Inventory Turnover | — | — | — | — | — | — |
| Days Sales Outstanding | — | 78.74 | 39.78 | 22.29 | 14.23 | 35.35 |
VSEE Shareholder Yields
Earnings, FCF, buyback, and dividend yields — total returns to shareholders
VSee Health, Inc. does not currently pay a dividend and has no material buyback yield, reinvesting earnings back into the business.
Dividends
Full dividend history and growth charts are on the Dividend History page
| Metric | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Dividend Yield | — | — | — | — | — | — |
| Payout Ratio | — | — | — | — | — | — |
Total Shareholder Return Metrics
| Metric | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Earnings Yield | — | — | — | — | — | — |
| FCF Yield | — | — | — | — | — | — |
| Buyback Yield | 0.0% | 0.0% | — | — | — | — |
| Total Shareholder Yield | 0.0% | 0.0% | — | — | — | — |
| Shares Outstanding | — | $10M | $10M | $10M | $10M | $10M |
Peer Comparison
Compare VSEE with 10 similar companies in its peer group
| Company | Market Cap | P/E | EV/EBITDA | P/FCF | Gross Margin | Op Margin | ROE | ROIC | Debt/EBITDA |
|---|---|---|---|---|---|---|---|---|---|
 VSEEYou | $3M | -0.0 | — | — | 68.9% | -596.4% | — | -1749.8% | — |
 TDOC | $1B | -6.1 | 15.1 | 4.4 | 69.5% | -10.4% | -13.9% | -11.5% | 10.4 |
 AMWL | $129M | -1.3 | — | — | 53.3% | -42.2% | -33.9% | -95.1% | — |
 OPRX | $124M | 24.6 | 6.5 | 6.6 | 67.3% | 10.7% | 4.2% | 7.1% | 0.3 |
 TALK | $868M | 129.5 | 137.8 | — | 43.0% | 1.4% | 6.6% | 3.9% | — |
 DOCS | $5B | 23.5 | 21.1 | 19.6 | 90.2% | 39.9% | 22.5% | 20.0% | 0.1 |
 HIMS | $7B | 50.3 | 42.7 | 89.6 | 59.3% | 5.2% | 25.2% | 10.7% | 6.4 |
 PHGE | $1B | -0.0 | — | — | — | — | -316.9% | -444.8% | — |
 VEEV | $27B | 30.9 | 28.4 | 19.3 | 75.5% | 28.7% | 13.9% | 12.9% | 0.1 |
 HCAT | $113M | -0.6 | — | — | 48.7% | -51.7% | -58.3% | -32.9% | — |
 GDRX | $973M | 33.3 | 4.0 | 5.9 | 82.1% | 13.4% | 4.5% | 13.0% | 0.3 |
| Healthcare Median | — | 22.3 | 14.4 | 18.5 | 63.9% | -5.2% | -33.7% | -11.2% | 3.3 |
Peer selection based on competitive and market overlap. Compare multiple stocks →
Download Financial Ratios Data
Includes 30+ ratios · 5 years · Updated daily
See VSEE's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs VSEE Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare VSEE vs TDOC
Side-by-side business, growth, and profitability comparison vs Teladoc Health, Inc..
Start ComparisonVSEE — Frequently Asked Questions
Quick answers to the most common questions about buying VSEE stock.
What is VSee Health, Inc.'s P/E ratio?
VSee Health, Inc.'s current P/E ratio is -0.0x. This places it at the 50th percentile of its historical range.
Is VSEE stock overvalued?
Based on historical data, VSee Health, Inc. is trading at a P/E of -0.0x. This is at the 50th percentile of its historical P/E range. Compare with industry peers and growth rates for a complete picture.
What are VSee Health, Inc.'s profit margins?
VSee Health, Inc. has 68.9% gross margin and -596.4% operating margin.